Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026

Go back to Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026
(NASDAQ: ACON) Delayed: 1.94 -0.01 (0.51%)
Previous Close $1.95    52 Week High $ 
Open $1.94    52 Week Low $ 
Day High $1.99    P/E N/A 
Day Low $1.90    EPS $ 
Volume 15,046       

(NASDAQ: ACONW) Delayed: 0.03 +0.01 (50.00%)
Previous Close $0.02    52 Week High $ 
Open $0.03    52 Week Low $ 
Day High $0.03    P/E N/A 
Day Low $0.02    EPS $ 
Volume 103,390